Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ovarian Neoplasms

Free Subscription 06.07.2026 3 BMC Cancer 2 Br J Cancer 1 Clin Cancer Res 4 Gynecol Oncol 1 Int J Gynaecol Obstet 1 J Natl Cancer Inst 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. JAGEMA T, Arusi T, Birara M, Hailu Y, et al
   Assessing the accuracy and applicability of the risk of malignancy index in predicting histopathological diagnoses of ovarian malignancy among patients at Saint Paul's Hospital Millennium Medical College in Addis Ababa, Ethiopia, in 2024.
   BMC Cancer. 2026 May 11. doi: 10.1186/s12885-026-16122.
   PubMed         Abstract available
   
   
2. BECK MH, Kordowitzki P, Roser E, Trelinska-Finger A, et al
   Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence.
   BMC Cancer. 2026;26:495.
   PubMed         Abstract available
   
   
3. LAMY C, Laurent L, Choussy O, Pouget N, et al
   SCANDARE: an institutional dynamic prospective interventional biobanking study.
   BMC Cancer. 2026;26:330.
   PubMed         Abstract available
   
   

   
   Br J Cancer

4. MEAGHER NS, White KK, Wilkens LR, Anton-Culver H, et al
   Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.
   Br J Cancer. 2026 Jun 30. doi: 10.1038/s41416-026-03509.
   PubMed         Abstract available
   
   
5. MONGIOVI JM, Babic A, Sasamoto N, Townsend MK, et al
   Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use.
   Br J Cancer. 2026 Jun 27. doi: 10.1038/s41416-026-03508.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

6. LAWN S, Hernandez Rojas A, Wong J, Degefie L, et al
   ZW191, an FRalpha-Targeted Topoisomerase 1 Inhibitor ADC with a Differentiated Antitumor Efficacy and Tolerability Profile.
   Clin Cancer Res. 2026;32:2748-2764.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

7. ROLLER L, Zhou N, Atre I, Xiong N, et al
   Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.
   Gynecol Oncol. 2026;211:98-107.
   PubMed         Abstract available
   
   
8. SHAHIN MS, Lorusso D, Backes FJ, Barretina-Ginesta MP, et al
   Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.
   Gynecol Oncol. 2026;211:79-88.
   PubMed         Abstract available
   
   
9. CHAMBERS LM, Spakowicz D, Chalif J, O'Connor R, et al
   PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.
   Gynecol Oncol. 2026;211:74-78.
   PubMed         Abstract available
   
   
10. KOURI A, Menzies A, Stearns K, McGough C, et al
    A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.
    Gynecol Oncol. 2026;211:67-73.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

11. GOTTHEIL C, Woolcott C, Marshall EG, Kieser K, et al
    Examining the diagnostic process for ovarian cancer in Nova Scotia: A linked administrative data study.
    Int J Gynaecol Obstet. 2026 Jun 30. doi: 10.1002/ijgo.71149.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

12. YU S, Wang X, Ge H
    Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25).
    J Natl Cancer Inst. 2026 Jun 30:djag212. doi: 10.1093.
    PubMed        
    
    

    
    Oncogene

13. CHEN Y, Lu D, Xing Y, He J, et al
    The translation landscape of ovarian clear cell carcinoma indicates that RBM4 plays a pro-oncogenic role in tumor progression.
    Oncogene. 2026 Jun 5. doi: 10.1038/s41388-026-03840.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum